With the approval of the shareholders' meeting of Nanjing Cisco Pharmaceutical Co., Ltd. and Nanjing Kang Hai Pharmaceutical Co., Ltd., it was decided to merge Nanjing Cisco Pharmaceutical Co., Ltd. and Nanjing Kang Hai Pharmaceutical Co., Ltd., and Nanjing Kang Hai Pharmaceutical Co., Ltd. was absorbed and merged. After the merger, Nanjing Kang Hai Pharmaceutical Co., Ltd. terminated its operation and cancelled its legal person status. The creditor's rights and debts of the former Nanjing Kang Hai Pharmaceutical Co., Ltd. were all inherited by Nanjing Cisco Pharmaceutical Co., Ltd.
The creditors of Nanjing Kang Hai Pharmaceutical Co., Ltd. are requested to declare their creditor's rights to Nanjing Kang Hai Pharmaceutical Co., Ltd. within 45 days from the first publication of this announcement, and Nanjing Kang Hai Pharmaceutical Co., Ltd. will confirm the relevant debts and negotiate the debt settlement plan. Failing to claim the rights to Nanjing Kang Hai Pharmaceutical Co., Ltd. within the time limit shall be deemed as giving up the relevant rights.
It is hereby announced.
Address: No.28 Gaoxin Road, Nanjing High-tech Industrial Development Zone
Nanjing Sike Drug Co., Ltd.
Nanjing Kang Hai Pharmaceutical Co., Ltd.
April 28, 2065 438+00